ClinicalTrials.Veeva

Menu

Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric Cancer

C

Corporacion Parc Tauli

Status

Unknown

Conditions

Polymerase Chain Reaction
Gastric Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT03098758
CIRPT_AL2017_1

Details and patient eligibility

About

Gastric carcinoma is a disease with a high mortality. Peritoneal washing cytology has a recognized prognostic utility. However sensibility of this study is not appropriate. Studies with PCR (polymerase chain retrotranscription) can increase sensibility and accurate staging information.

Objective: To analyze the sensibility and specificity of the expression of CK20, CEA and Ber-EP4 with PCR technique in peritoneal washings of advanced gastric carcinoma without clinical evidence of peritoneal carcinomatosis.

Methodology: Retrotranscription analysis (RT-PCR) and quantitative PCR (qPCR) of CK20, CEA and Ber-EP4 in peritoneal washing. Test the feasibility of qPCR with this new marker (Ber-EP4). Comparison of the results with data obtained with conventional cytology. Study of peritoneal recurrence.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with resectable advanced gastric cancer
  • Informed consent

Exclusion criteria

  • Macroscopic peritoneal carcinomatosis
  • Non operable patients

Trial contacts and locations

1

Loading...

Central trial contact

Alexis Luna, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems